MedTrace Logo

Optimal TCI Regimen for Sedation of Elderly Undergoing Fiberoptic Bronchoscopy

NCT02927587 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2016-10-07

No results posted yet for this study

Summary

Target-Controlled Infusion (TCI) of Propofol has been proved to be a safe agent for conscious sedation in flexible bronchoscopy (FB) .However, the target setting of "effect-site" concentration (Cet) of propofol is still unclear in the elderly population .The aim of this study was to compare two induction Cet of propofol in elderly patients undergoing flexible bronchoscopy.

Conditions

  • Adverse Effects

Interventions

DRUG

The induction Cet of propofol

The induction Cet of propofol was targeted respectively at 1 and 2 ug/ml.

Sponsors & Collaborators

  • The Second Affiliated Hospital of Dalian Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-03-31
Completion
2016-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02927587 on ClinicalTrials.gov